Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Pfizer Board of Directors, the most common co-covered peer. We currently track 1 Biotech story that mention Pfizer Inc., all published on September 13, 2026.
Last mentioned: 1d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Pfizer Board of Directors, the most common co-covered peer. We currently track 1 Biotech story that mention Pfizer Inc., all published on September 13, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pfizer Inc.. Shared-story counts are live from our verified record — not editorial picks.
Pfizer paid $4.9B in dividends during H1 2026, backed by $12.7B in cash and short-term investments. While the cash dividend payout ratio is roughly 90%, biopharma investors may weigh this against pipeline and M&A capital needs.
Source: The Motley Fool · fool.com
Pfizer Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
